Table 1.
Target protein | DNA repair pathway | Modifier | Result |
---|---|---|---|
MGMT | DR | Poly-ubiquitin & 26S proteasome | Degradation |
hMutSa complex (MSH2/MSH6) | MMR | Poly-ubiquitin & 26S proteasome | Degradation |
NEDD8 | Unknown | ||
hEXO1b | MMR | Poly-ubiquitin & 26S proteasome | Degradation |
TDG | BER | Poly-ubiquitin & 26S proteasome | Degradation |
SUMO | Release from DNA | ||
UNG2 | BER | Poly-ubiquitin & 26S proteasome | Degradation |
PARP-1 | BER | Poly-ubiquitin | Degradation |
26S proteasome | |||
Ubc9/SUMO | Deceleration of DNA synthesis for DNA repair prior to replication | ||
XRCC1 | BER | SUMO | Unknown |
XPC | NER | Poly-ubiquitin | Increased DNA-binding |
26S proteasome | Degradation | ||
SUMO | Stabilisation | ||
HR23 | NER | 26S proteasome | Binding to 26S proteasome, inhibition of XPC |
19S proteasome | Multi-ubiquitylation | ||
DDB2 | NER | Poly-ubiquitin & 26S proteasome | Degradation |
Rad51 | HR | Poly-ubiquitin & 26S proteasome | Degradation |
19S proteasome (DSS1) | Rad51 focus formation, binding at DNA-damage site | ||
SUMO | Nuclear trafficking | ||
NEDD8 | Unknown | ||
Rad52 | HR | SUMO | Protection from degradation, accumulation after DNA damage |
Ku70 | NHEJ | Poly-ubiquitin & 26S proteasome | Degradation |
Ku80 | NHEJ | Poly-ubiquitin & 26S proteasome | Degradation |
SUMO | Unknown | ||
XRCC4 | NHEJ | Mono-ubiquitin | Lig 4 stabilisation, damage foci & DNA binding, interaction with NHEJ proteins |
SUMO | Warrants further examination | ||
DNA PKcs | NHEJ | NEDD8 | Unknown |
PCNA | TLS | Mono-ubiquitin | Recruitment of TLS polymerases |
SUMO | HR inhibition, Pol ζ recruitment | ||
Poly-ubiquitin | Switch to damage avoidance sub-pathway | ||
Rad18 | TLS | Poly-ubiquitin & 26S proteasome | Degradation |
Mono-ubiquitin | Equilibration between nuclear and cytoplasmic protein levels | ||
Pol η | TLS | Poly-ubiquitin & 26S proteasome | Degradation |
Pol δ, ɛ, ζ | NEDD8 | Unknown | |
p12 subunit of Pol δ | MMR, BER, NER, HR | Poly-ubiquitin & 26S proteasome | Degradation |
p66 subunit of Pol δ | MMR, BER, NER, HR | Mono-ubiquitin | Conformation change (affecting the overall structure & function of the polymerase complex) |
Poly-ubiquitin | |||
SUMO | |||
FANCC | FA | Poly-ubiquitin & 26S proteasome | Degradation |
FANCD2 | FA | Mono-ubiquitin | Interaction with FANCI, chromatin targeting |
FANCI | FA | Mono-ubiquitin | Interaction with FANCD2, chromatin targeting |
Abbreviations: MGMT, O6-methylguanine-DNA methyltransferase; DR, direct repair; MSH2, MutS homologue 2; MSH6, MutS homologue 6; MMR, mismatch-repair; NEDD8, neural precursor cell expressed developmentally down-regulated 8; hEXO1b, human exonuclease 1b; TDG, thymine-DNA glycosylase; BER, base-excision repair; SUMO, small ubiquitin-like modifier; UNG2, uracil-DNA glycosylase 2; PARP-1, poly-ADP-ribose polymerase; Ubc9, ubiquitin-conjugating enzyme 9; XRCC1, X-ray repair complementing defective repair in Chinese hamster cells 1; XPC, Xeroderma pigmentosum, complementation group C; NER, nucleotide-excision repair; HR23, homologue of Rad23; DDB2, damage-specific DNA binding protein 2; HR, homologous recombination; NHEJ, non-homologous end joining; XRCC4, X-ray repair complementing defective repair in Chinese hamster cells 4; Lig 4, DNA-ligase 4; DNA-PKcs, DNA-dependent protein kinase catalytic subunit; PCNA, proliferating cell nuclear antigen protein; TLS, translesion DNA synthesis; Pol η, DNA polymerase η; Pol δ, ɛ, ζ, DNA polymerases δ, ɛ, ζ; FANCC, Fanconi anaemia, complementation group C; FANCD2, Fanconi anaemia complementation group D2; FANCI, Fanconi anaemia complementation group I.